RTSN
Retension Pharmaceuticals, Inc. · Healthcare
Chief Executive Officer Eric L. Keller bought $250K of Retension Pharmaceuticals, Inc.
Bought$249,600
$12.00Price
20,800Shares
+5%Stake
What RTSN did for a copier
- $1,000 copied at Wed, Oct 14 open, $11.63
- $1,210
- S&P 500, same days
- −1.5%
2 of 30 trading days so far, to the Oct 16 close.
Eric L. Keller's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Oct 13. Filed Tue, Oct 13, 6:12 PM ET, after the close. Returns use the Oct 14 open and the Oct 16 close. Not investment advice.